Cafepharma Today

May 16 2025 - Novo CEO to depart as obesity drugmaker’s challenges rise
Novo CEO to depart as obesity drugmaker’s challenges rise
BioMarin expands enzyme expertise with $270M Inozyme buy
Amgen could owe Regeneron more than $400M after defeat in cholesterol drug antitrust suit
Eli Lilly collaborates with Rznomics on hearing loss treatment in $1.3 billion pact
*please scroll down for all the latest news *

Make it like cafepharma, but for different industries. Learn more about CompanyUnderground

Check open job listings in your area
Click here to stay updated on CP happenings

learn about pharmaceutical fraud
learn about the False Claims Act
learn about clinical lab fraud

Current News

submit a press release

White House supports FDA bill
The Hill, DC
Friday, May 18, 2012 - 12:38pm
tags:
FDA, Obama, biosimilars, innovation
Doctors ditching the prescription pad as more than a third of prescriptions now are electronic
Washington Post, DC
Friday, May 18, 2012 - 12:37pm
tags:
physicians, e-prescribing
Rexahn Pharmaceuticals: Update On Cancer Drugs
Seeking Alpha
Friday, May 18, 2012 - 11:00am
tags:
Teva Pharmaceuticals, Rexahn, Archexin, RX-3117, RX-5902, RX-8243, cancer, akt protein inhibitor
Warner Chilcott Sues Watson Over Generic Contraceptive
Bloomberg
Friday, May 18, 2012 - 10:58am
tags:
Warner Chilcott, lawsuits, Watson Pharmaceuticals, generics, contraceptives, Lo Loestrin Fe, birth control pill
Analysts' Actions: AZO, BMY, LLY, MS
TheStreet.com
Friday, May 18, 2012 - 10:55am
tags:
Eli Lilly, Bristol-Myers Squibb
5 Pharmaceutical Stocks With Significant Exposure to Europe
Motley Fool
Friday, May 18, 2012 - 10:54am
tags:
Europe, Merck, JNJ, Pfizer, Abbott Laboratories, Bristol-Myers Squibb
J&J Recall Watch: McNeil Recalls Imodium Lot
WSJ Online
Friday, May 18, 2012 - 10:53am
tags:
JNJ, recalls, McNeil, Imodium
ASCO '12 Abstract Dump: Cancer Stocks in Focus
TheStreet.com
Thursday, May 17, 2012 - 10:35am
tags:
ASCO, Array Biopharma, Exelixis, Pharmacyclics, Onyx, Seattle Genetics, Aveo, Ariad Pharmaceuticals, Arqule, Oncothyreon
Array shares rise on lung cancer, melanoma results
Reuters
Thursday, May 17, 2012 - 10:32am
tags:
lung cancer, melanoma, Array Biopharma, selumetinib
Amgen Revives Defunct Drug as Old Therapies Seek New Cure
Bloomberg
Thursday, May 17, 2012 - 10:30am
tags:
Amgen, rilotumumab, gastric cancer
Dendreon’s Provenge Works Best for Patients With Low PSA, Scientists Say
Xconomy
Thursday, May 17, 2012 - 10:28am
tags:
PSA, prostate cancer, Dendreon
Plavix’s Loss Means Little Gain by Competing Blood Thinners
Bloomberg
Thursday, May 17, 2012 - 10:26am
tags:
Plavix, bloodthinners, patents, Sanofi, Bristol-Myers Squibb, AstraZeneca, Eli Lilly
Acorda Therapeutics To FDA: What Deadlines?
Pharmalot
Thursday, May 17, 2012 - 10:23am
tags:
FDA, Acorda Therapeutics, adverse events, AMPYRA
Popular antibiotic linked with rare heart-related deaths in 14-year study of Medicaid patients
Yahoo/AP
Thursday, May 17, 2012 - 10:22am
tags:
antibiotics, Zithromax, Pfizer
Your Warning Label Is My Sales Brochure
Motley Fool
Thursday, May 17, 2012 - 10:20am
tags:
warnings, MS, Gilenya, multiple sclerosis, Novartis, Biogen Idec, Bayer, Teva Pharmaceuticals, Elan, Pfizer
Abbott Stands Up to Obamacare
Motley Fool
Thursday, May 17, 2012 - 10:19am
tags:
healthcare reform, Obama, Abbott Laboratories, biosimilars, Humira
Drug Fails: At Least It's Approved Already
Motley Fool
Thursday, May 17, 2012 - 10:17am
tags:
Motley Fool, Pfizer, Torisel, Sutent, kidney cancer
J&J’s Zytiga Helps Eliminate Early-Stage Prostate Cancer
Bloomberg
Thursday, May 17, 2012 - 10:16am
tags:
JNJ, Zytiga, prostate cancer
Pfizer Lung Drug Stops Deadly Child Cancers in Study
Bloomberg
Thursday, May 17, 2012 - 10:15am
tags:
Pfizer, Xalkori, anaplastic large-cell lymphoma
Abbott Helps Big Pharma Look Even Worse
TheStreet.com
Wednesday, May 16, 2012 - 1:39pm
tags:
Abbott Laboratories, Depakote

Pages

Latest CP Wire Articles

Hermes Intelligence Launches to Redefine Pharma Data Solutions [sponsored]
The Evolution of Medical Sales: What’s Changing in 2025?
FDA Scraps Key Vaccine Meetings—What It Means for Manufacturers
FDA approves Danziten, the first nilotinib treatment for Ph+ CML with no mealtime restrictions
Daily U.S. Flu Cases Expected to Nearly Double from Last Year by Late November, Predicts Novel Mathematical Forecasting Tool
PharmaBlock Receives 2024 ACS CMO Excellence in Green Chemistry Award, Marking a Second Consecutive Year of Recognition
Leading Clinical Research Network Centricity Research Acquires North Carolina-based Lucas Research
First-of-Its-Kind Alzheimer’s Disease Simulation Paves Way for Personalized Treatment: Penn State, Duke University Study
Centricity Research Appoints New CEO, CFO to Support Next Phase of Growth
Sermo Barometer Examines Influencers’ Impact on Patient Perceptions of Weight Loss Medications & Preventative Care Technologies

Latest Pharmagather Articles

Alzheimer's Update: Infectious Agents and Gamma-Secretase Too
In the Pipeline
Obesity Without Metabolic Dysfunction?
In the Pipeline
New Cell Therapy For Resistant Hodgkins Patients
In the Pipeline
Escape From the Lysosome
In the Pipeline
Heavy Water in Your NMR Experiments, And Elsewhere
In the Pipeline
GIPR: Agonists and Antagonists Do the Same Thing, But How
In the Pipeline
Mutant Proteins Classified
In the Pipeline
The Continuing Crisis, Part XIV: The Trumpist Worldview
In the Pipeline
Whole Lotta Snakin' Going On
In the Pipeline

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.